CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Current Assets:
Cash and cash equivalents	$ 137,160	$ 120,614	[1]
Trade accounts receivable, net of allowances of $5,223 and $6,194	118,262	118,145	[1]
Inventories, net	223,632	206,919	[1]
Deferred tax assets	48,349	48,616	[1]
Prepaid expenses and other current assets	36,758	26,858	[1]
Total current assets	564,161	521,152	[1]
Property, plant and equipment, net	206,668	200,310	[1]
Intangible assets, net	422,009	197,163	[1]
Goodwill	354,977	249,764	[1]
Deferred tax assets	6,422	15,412	[1]
Other assets	8,786	8,338	[1]
Total assets	1,563,023	1,192,139	[1]
Current Liabilities:
Accounts payable, trade	47,004	50,752	[1]
Deferred revenue	4,411	4,197	[1]
Accrued compensation	36,595	28,079	[1]
Accrued expenses and other current liabilities	38,892	36,354	[1]
Total current liabilities	126,902	119,382	[1]
Long-term borrowings under senior credit facility	421,875	186,875	[1]
Long-term convertible securities	209,096	205,182	[1]
Deferred tax liabilities	81,540	2,083	[1]
Other liabilities	34,380	12,527	[1]
Total liabilities	873,793	526,049	[1]
Commitments and contingencies			[1]
Stockholders’ Equity:
Preferred Stock; no par value; 15,000 authorized shares; none outstanding	0	0	[1]
Common stock; $0.01 par value; 60,000 authorized shares; 41,474 and 41,042 issued at June 30, 2014 and December 31, 2013, respectively	415	410	[1]
Additional paid-in capital	766,096	750,918	[1]
Treasury stock, at cost; 8,903 shares at June 30, 2014 and December 31, 2013	(367,121)	(367,121)	[1]
Accumulated other comprehensive income (loss)	1,853	927	[1]
Retained earnings	287,987	280,956	[1]
Total stockholders’ equity	689,230	666,090	[1]
Total liabilities and stockholders’ equity	$ 1,563,023	$ 1,192,139	[1]

[1] See Note 1 of these condensed consolidated financial statements for discussion of the impact of the change in accounting for the medical device excise tax.